Clinical Trials · NCT06225284
Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- National Taiwan University Hospital
- Enrollment
- 124
- Start date
- Aug 2024
- Locations
- 1 site, Taiwan
- Primary endpoint
- Pathological complete response rate